Silverarc Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.6M | Sell |
|
|||||
|
2025
Q2 | $14.9M | Buy |
|
|||||
|
2025
Q1 | $11.8M | Buy |
|
|||||
|
2024
Q4 | $7.09M | Buy |
|
|||||
|
2024
Q3 | $747K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2.83M | Buy |
|
|||||
|
2022
Q3 | $516K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.43K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $737 | Sell |
|
|||||
|
2021
Q1 | $2.41M | Buy |
|
|||||
|
2020
Q4 | $2.93M | Buy |
|